Roche Holding Ltd. (ROG) Stock Rating Reaffirmed by JPMorgan Chase & Co.
Roche Holding Ltd. (VTX:ROG)‘s stock had its “buy” rating reissued by JPMorgan Chase & Co. in a research note issued to investors on Monday.
A number of other brokerages have also recently issued reports on ROG. Citigroup Inc. restated a “buy” rating on shares of Roche Holding in a report on Wednesday, July 27th. Goldman Sachs Group Inc. restated a “buy” rating on shares of Roche Holding in a report on Tuesday, July 19th.
Shares of Roche Holding (VTX:ROG) opened at 238.30 on Monday. The company has a market cap of CHK 203.07 billion and a PE ratio of 21.85. The firm’s 50-day moving average price is CHK 241.71 and its 200-day moving average price is CHK 245.92. Roche Holding has a 12 month low of CHK 229.90 and a 12 month high of CHK 281.40.
Roche Holding Company Profile
Roche Holding AG is a research-based healthcare company. The Company develops, manufactures and delivers medicines, and diagnostic instruments and tests. Its operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. Its Pharmaceuticals division consists of two business segments: Roche Pharmaceuticals and Chugai.
Receive News & Stock Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related stocks with our FREE daily email newsletter.